AusHealth announces the CureCell Award Winners for 2024.

Fantastic to be able to say thank you to our second corporate donor – Kit Legal Pty Ltd.

Introducing Jacqueline Scaffidi as CureCell's Communications and Engagement Officer.

Lizamarie Goonetilleke is one of CureCell’s 2022 Honours scholarship recipients. Lizamarie is currently undertaking her honours degree within the Reproductive Cancer Research Group at the University of Adelaide.

PhD student Hannah Hughes-Parry is CureCell’s most recent PhD top up scholarship recipient. Hannah is part of the Misty Jenkins lab within the immunology division at WEHI - The Walter and Eliza Hall Institute.

We are very pleased and excited to announce that Avatar Brokers Pty Limited have come on board as CureCell's very first corporate sponsor. Avatar is a specialist brokerage working with developers of innovative solutions for key world issues – a perfect fit for CureCell.

It has been 10 years since Emily Whitehead became the world’s first paediatric patient to receive CAR T cell therapy, a then-experimental ‘living drug’ made of her own immune cells developed by Penn Medicine.

Izac Findlay (right), recipient of CureCell’s inaugural Phd top up scholarship with A/Prof Matt Dun at the University of Newcastle.

CureCell is very pleased to announce the appointment of Robyn Faber to CureCell’s Board of Directors. Robyn brings to CureCell a diverse skill set, high energy, integrity and, importantly, an ultra positive mindset.

On Tuesday, 23 November at UniSA’s fantastic MOD Museum, CureCell held its long-awaited launch. Our inaugural Di Wood CureCell Scholarship recipients, Emma Roberts & Emily Freimayer, were there, fresh from completing their Honours year.